Total Funding
61
69
Total FundingSeed raised
Growth Score 61 in past quarter
-26 pts
Heat Score 69 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
104992
VOTIS provides clinical decision assistance for foot ulcers syndrome and associated diseases.
- Andreas H. Hielscher: Co-Founder & Chief Technology Advisor
Stuart Jacobowitz: Chief Financial OfficerPast Role: FreeMind, Senior Director of Business Development
About the Company
VOTIS Subdermal Imaging Technologies help diabetics keep their feet through early screening for peripheral vascular disease and related complications. Early screening can offer new treatment options and help reduce incidents of amputation. Their device is non-invasive and contact-free, not based on radiation, and functionally consistent with the
guidelines of the AHA, the American Diabetes Association, and other leading medical organizations. It will reduce healthcare costs for hospitals, clinics, and insurers.